Compare General Dynamics Corporation (GD) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Dynamics Corporation vs Zimmer Biomet Holdings Inc — how do they compare? General Dynamics Corporation trades at $393.49 (market cap $106.03B), while Zimmer Biomet Holdings Inc trades at $97 (market cap $18.55B). The key difference: General Dynamics Corporation is far larger — about 5.7× Zimmer Biomet Holdings Inc's market cap, and General Dynamics Corporation pays the higher dividend (1.62%). Which is the better fit depends on your goals.
| GD | ZBH | |
|---|---|---|
Market Cap | $106.03B | $18.55B |
Sector | Industrials | Health |
52-Week High | $395.97 | $107.71 |
52-Week Low | $312.53 | $79.58 |
Enterprise Value | $111.17B | $25.61B |
Dividend Yield | 1.62% | 0.99% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About General Dynamics Corporation
General Dynamics is a defense contractor and business jet manufacturer. The firm's segments include aerospace, combat systems, marine, and technologies. The company's aerospace segment creates Gulfstream business jets. Combat system produces land-based combat vehicles, such as the M1 Abrams tank. The marine subsegment creates nuclear-powered submarines, among other things. The technologies segment contains two main units, an IT business that primarily serves the government market and a mission systems business that focuses on products that provide command, control, computers, intelligence, surveillance, and reconnaissance capabilities to the military.
Read more on GD →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
